India's science and health ministries are to cooperate on guidelines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Related links
Related links
Related links in Nature Research
http://www.nature.com/doifinder/10.1038/431885a
Related external links
Rights and permissions
About this article
Cite this article
Jayaraman, K. Indian regulations fail to monitor growing stem-cell use in clinics. Nature 434, 259 (2005). https://doi.org/10.1038/434259a
Published:
Issue date:
DOI: https://doi.org/10.1038/434259a
This article is cited by
-
Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement
European Spine Journal (2019)
-
The global industry for unproven stem cell interventions and stem cell tourism
Tissue Engineering and Regenerative Medicine (2014)
-
India's first true stem cell trials
Nature Biotechnology (2009)
-
Unchecked by guidelines, Indian stem cell scientists rush ahead
Nature Medicine (2006)
-
Australia considers changing laws to allow therapeutic cloning
Nature Medicine (2006)